Press release
Thalassemia Market to reach USD 6.72 Bn by 2029, emerging at a CAGR of 9.8 percent and forecast 2023-2029
Thalassemia Market
The comprehensive Thalassemia Market report provides insights into the hereditary blood illness, covering market dynamics, drivers, restraints, and regional perspectives. The research delves into the current state of the Thalassemia Market, offering a detailed analysis of its scope and future prospects.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/market-report/thalassemia-market/126529/
Thalassemia Market Research Methodology
The report employs a rigorous research methodology to present a thorough analysis of the Thalassemia Market. The data is gathered through extensive research, ensuring accuracy and reliability. To gain a deeper understanding, stakeholders can request a free sample report.
What are Thalassemia Market Dynamics:
The Thalassemia Market is expected to reach US$ 6.72 billion by 2029, primarily driven by growth in the industrial product segment. The report analyzes market dynamics regionally and within the Pipeline industries, identifying key factors propelling market expansion.
Thalassemia Market Regional Insights:
North America is projected to dominate the global Thalassemia treatment market, fueled by factors such as the presence of major companies, a high prevalence of thalassemia patients, and established healthcare infrastructure. The report provides a detailed analysis of regional dynamics, including growth drivers and potential challenges.
Request For Customization Report: https://www.maximizemarketresearch.com/request-sample/126529
What is Thalassemia Market Segmentation:
by Product
Iron Chelating Drugs
Exjade/Jadenu (deferasirox)
Blood Transfusions
Folic Acid Supplements
Others
by Type
Gene Therapy
LentiGlobin
Who are Thalassemia Market Key Players:
1. bluebird bio, Inc.
2. Acceleron Pharma, Inc.
3. Celgene Corporation
4. GlaxoSmithKline plc
5. Incyte Corporation
6. Gamida Cell
7. Kiadis Pharma
8. La Jolla Pharmaceutical Company
9. IONIS Pharmaceuticals
10. Acceleron Pharma
11. Novartis AG
12. Pharmaceuticals Inc
13. Alnylam Pharmaceuticals Inc
14. Calimmune Inc
15. CRISPR Therapeutics
16. Editas Medicine Inc
17. Errant Gene Therapeutics LLC
18. Gamida Cell Ltd
19. Gilead Sciences Inc
20. Incyte Corp
21. Ionis Pharmaceuticals Inc
To remain 'ahead' of your competitors, request a sample@https://www.maximizemarketresearch.com/request-sample/126529
The table of contents for the Thalassemia Market includes:
Global Thalassemia Market: Research Methodology
Global Thalassemia Market: Executive Summary
Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry
Global Thalassemia Market: Competitive Analysis
MMR Competition Matrix
Market Structure by Region
Competitive Benchmarking of Key Players
Consolidation in the Market
MandA by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact
4. Company Profile: Key players
Company Overview
Financial Overview
Global Presence
Capacity Portfolio
Business Strategy
Recent Developments
Key Offerings:
Past Market Size and Competitive Landscape (2022 to 2029)
Past Pricing and price curve by region (2022 to 2029)
Market Size, Share, Size, and Forecast by Different Segments | 2022-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by growth and trend
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
More Related Reports:
GingerOleoresin Market https://www.maximizemarketresearch.com/market-report/ginger-oleoresin-market/191115/
Transcatheter Embolization and Occlusion Devices Market https://www.maximizemarketresearch.com/market-report/transcatheter-embolization-and-occlusion-devices-market/200523/
Cartilage Repair and Cartilage Regeneration Market https://www.maximizemarketresearch.com/market-report/cartilage-repair-and-cartilage-regeneration-market/200522/
Bird Repellent Market https://www.maximizemarketresearch.com/market-report/bird-repellent-market/201248/
Agar Market https://www.maximizemarketresearch.com/market-report/agar-market/199693/
Gasification Market https://www.maximizemarketresearch.com/market-report/gasification-market/214423/
Electronics Manufacturing Services Market https://www.maximizemarketresearch.com/market-report/global-electronics-manufacturing-services-market/112137/
Mining Automation Market https://www.maximizemarketresearch.com/market-report/global-mining-automation-market/63058/
Global Critical Limb Ischemia Treatment Market https://www.maximizemarketresearch.com/market-report/global-critical-limb-ischemia-treatment-market/39239/
Industrial Control and Factory Automation Market https://www.maximizemarketresearch.com/market-report/global-industrial-control-and-factory-automation-market/24427/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT and telecom, chemical, food and beverage, aerospace and defense, healthcare, and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thalassemia Market to reach USD 6.72 Bn by 2029, emerging at a CAGR of 9.8 percent and forecast 2023-2029 here
News-ID: 3323643 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a …
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.…
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,…
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to …
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range of…
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR …
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizes…
More Releases for Thalassemia
Beta Thalassemia Market Trends, Treatment Landscape, and Growth Opportunities
Introduction
Beta thalassemia is a genetic blood disorder caused by mutations in the beta-globin gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This results in anemia, fatigue, and a range of complications that can be life-threatening if untreated. The severity of beta thalassemia varies from thalassemia minor, which typically requires no treatment, to thalassemia major (Cooley's anemia), which can lead to severe symptoms and require frequent…
Global Thalassemia Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and…
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such that…
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy…
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms…
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia…
